Last reviewed · How we verify

NCT05250986: VA IR vs IO

Comparison of Visual Acuity Performed in Office Versus In Residence

Status unknown Last updated 22 February 2022
What this trial tests

trial testing GoCheck Kids (iOS) in Refractive Errors in 325 participants. Status unknown.

Timeline
14 February 2022
Primary endpoint
31 May 2022
1 September 2022

Quick facts

Lead sponsorGobiquity Mobile Health
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment325
Start date14 February 2022
Primary completion31 May 2022
Estimated completion1 September 2022
Sites4 locations across United States, Israel

Drugs / interventions tested

Conditions studied

Sponsor

Gobiquity Mobile Health

Who can join

Adults 4 to 20, any sex, with Refractive Errors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

GoCheck has developed and deployed a home-based visual acuity test that may be used in-office or in residence. The test methodology utilizes modified ATS and ETDRS protocols with Sloan optotypes, crowding bars and sophisticated algorithms. The objective of this study is to determine if the results of the GoCheck visual acuity test performed in an office setting correlate to the same testing when implemented in the residence

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Refractive Errors

Currently open trials in the same condition.

Other Gobiquity Mobile Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05250986.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing